Why Robert Ortenzio Sold 192,853 Shares of Select Medical Holdings (SEM)?; Sachem Head Capital Management LP Has Raised Its Facebook (FB) Position

Facebook, Inc. (NASDAQ:FB) Logo

Sachem Head Capital Management Lp increased Facebook Inc (FB) stake by 80.7% reported in 2018Q1 SEC filing. Sachem Head Capital Management Lp acquired 920,000 shares as Facebook Inc (FB)’s stock declined 0.01%. The Sachem Head Capital Management Lp holds 2.06M shares with $329.17 million value, up from 1.14 million last quarter. Facebook Inc now has $556.93 billion valuation. The stock increased 0.45% or $0.86 during the last trading session, reaching $192.4. About 10.48 million shares traded. Facebook, Inc. (NASDAQ:FB) has risen 21.69% since June 13, 2017 and is uptrending. It has outperformed by 9.12% the S&P500. Some Historical FB News: ; 28/03/2018 – UK INTERIOR MINISTER RUDD SAYS INTERNET FIRMS SUCH AS FACEBOOK FB.O COULD DO MORE TO COMBAT ILLEGAL AND OFFENSIVE MATERIAL ON WEBSITES; 28/03/2018 – Facebook to introduce new privacy controls in wake of data scandal; 28/03/2018 – Facebook CEO Mark Zuckerberg summoned again by UK lawmakers to give evidence on data scandal; 13/04/2018 – WV MetroSources: Facebook removes opioid ads; 17/04/2018 – OROMIA ADMINISTRATION AND SECURITY BUREAU COMMENTS ON FACEBOOK; 20/03/2018 – China Xinhua News: #BREAKING: British parliament summons #Facebook founder #MarkZuckerberg to explain claims that massive user; 10/04/2018 – ZUCKERBERG SAYS OF FACEBOOK TERMS OF SERVICE: ‘l DON’T THINK THAT THE AVERAGE PERSON LIKELY READS THAT WHOLE DOCUMENT’; 27/03/2018 – The REALLY interesting part of this article, which mentions it as an aside, is that Eric Schmidt’s daughter interned at Cambridge parent (defense contractor) SCL; 19/03/2018 – Facebook is testing monthly subscription plans and connect advertisers for branded content opportunities with its video creators; 11/04/2018 – Facebook CEO Faces Congress: More Questions About Bias

Among 55 analysts covering Facebook (NASDAQ:FB), 51 have Buy rating, 2 Sell and 2 Hold. Therefore 93% are positive. Facebook had 273 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Facebook, Inc. (NASDAQ:FB) earned “Buy” rating by Monness on Wednesday, May 2. FBN Securities maintained Facebook, Inc. (NASDAQ:FB) rating on Tuesday, September 26. FBN Securities has “Buy” rating and $210.0 target. Goldman Sachs maintained Facebook, Inc. (NASDAQ:FB) rating on Friday, July 21. Goldman Sachs has “Buy” rating and $18000 target. Mizuho maintained Facebook, Inc. (NASDAQ:FB) on Thursday, July 30 with “Buy” rating. The company was maintained on Thursday, July 13 by BMO Capital Markets. Mizuho maintained the shares of FB in report on Thursday, November 3 with “Buy” rating. The rating was maintained by Axiom Capital on Thursday, November 3 with “Buy”. Jefferies maintained it with “Buy” rating and $19200 target in Monday, June 5 report. The firm has “Buy” rating by Nomura given on Thursday, November 5. The rating was maintained by Canaccord Genuity on Tuesday, September 5 with “Buy”.

More notable recent Facebook, Inc. (NASDAQ:FB) news were published by: Seekingalpha.com which released: “Best Tech Stock: Facebook Vs. Microsoft” on June 12, 2018, also Livetradingnews.com with their article: “How Expensive is Facebook, Inc. (NASDAQ:FB) Stock” published on June 13, 2018, Nasdaq.com published: “Facebook Inc (FB) Beefs Up Instagram Videos to Challenge Rivals” on June 07, 2018. More interesting news about Facebook, Inc. (NASDAQ:FB) were released by: Seekingalpha.com and their article: “Vietnam passes cyber law that could hurt Facebook, Google” published on June 12, 2018 as well as Livetradingnews.com‘s news article titled: “Facebook, Inc. (NASDAQ:FB) Entry at $170.00” with publication date: June 12, 2018.

Investors sentiment decreased to 0.87 in 2018 Q1. Its down 0.34, from 1.21 in 2017Q4. It dropped, as 145 investors sold FB shares while 712 reduced holdings. 173 funds opened positions while 573 raised stakes. 1.65 billion shares or 2.41% more from 1.61 billion shares in 2017Q4 were reported. 1,623 were accumulated by Lynch And Associate In. Tiger Eye Cap Ltd holds 5,635 shares. Sun Life Fincl stated it has 1,740 shares. Palisade Capital Limited Company Nj reported 31,650 shares. Shelton Mgmt has invested 2.84% in Facebook, Inc. (NASDAQ:FB). Harvest Mgmt Inc stated it has 2,050 shares or 0.13% of all its holdings. Synovus Fincl has invested 0.27% in Facebook, Inc. (NASDAQ:FB). Hayek Kallen Investment reported 1,450 shares stake. Ntv Asset Mngmt Limited Liability Company accumulated 29,477 shares. Moreover, Alpha Cubed Limited Liability has 0.69% invested in Facebook, Inc. (NASDAQ:FB) for 33,016 shares. Welch Forbes holds 232,895 shares or 0.96% of its portfolio. Lazard Asset Llc holds 542,024 shares or 0.16% of its portfolio. Bangor Comml Bank holds 8,026 shares or 0.25% of its portfolio. 145,000 were accumulated by Moore Capital Mngmt L P. Falcon Edge Capital Limited Partnership holds 151,000 shares or 4.41% of its portfolio.

Since December 19, 2017, it had 0 insider purchases, and 65 selling transactions for $2.97 billion activity. Shares for $72.43 million were sold by Zuckerberg Mark on Monday, April 16. $231.84 million worth of Facebook, Inc. (NASDAQ:FB) shares were sold by Koum Jan. $3.29 million worth of Facebook, Inc. (NASDAQ:FB) was sold by FISCHER DAVID B.. The insider Cox Christopher K sold 10,600 shares worth $1.96 million. Another trade for 4,761 shares valued at $880,309 was made by Wehner David M. on Monday, May 21. Schroepfer Michael Todd also sold $4.82 million worth of Facebook, Inc. (NASDAQ:FB) on Thursday, February 15. Stretch Colin also sold $134,821 worth of Facebook, Inc. (NASDAQ:FB) on Tuesday, December 19.

Another recent and important Select Medical Holdings Corporation (NYSE:SEM) news was published by Benzinga.com which published an article titled: “Benzinga’s Top Upgrades, Downgrades For June 4, 2018” on June 04, 2018.

Among 9 analysts covering Select Medical Holdings (NYSE:SEM), 5 have Buy rating, 1 Sell and 3 Hold. Therefore 56% are positive. Select Medical Holdings has $26.0 highest and $8 lowest target. $18.89’s average target is 1.29% above currents $18.65 stock price. Select Medical Holdings had 29 analyst reports since August 5, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Friday, October 16 by TheStreet. The rating was downgraded by Wells Fargo on Monday, January 30 to “Market Perform”. The firm has “Buy” rating by Robert W. Baird given on Sunday, October 15. RBC Capital Markets maintained Select Medical Holdings Corporation (NYSE:SEM) on Monday, August 7 with “Buy” rating. RBC Capital Markets maintained Select Medical Holdings Corporation (NYSE:SEM) rating on Monday, November 13. RBC Capital Markets has “Buy” rating and $19.0 target. RBC Capital Markets maintained it with “Outperform” rating and $21.0 target in Monday, August 10 report. On Monday, April 3 the stock rating was maintained by Benchmark with “Buy”. On Tuesday, October 6 the stock rating was upgraded by Wells Fargo to “Outperform”. The firm has “Buy” rating by RBC Capital Markets given on Monday, September 11. The stock of Select Medical Holdings Corporation (NYSE:SEM) has “Mkt Underperform” rating given on Wednesday, September 28 by JMP Securities.

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates specialty hospitals, outpatient rehabilitation clinics, and occupational medicine centers in the United States. The company has market cap of $2.50 billion. The companyÂ’s Specialty Hospitals segment operates long term acute care hospitals and inpatient acute rehabilitative hospitals. It has a 14.03 P/E ratio. This segment offers various medical services for the treatment of respiratory failure, neuromuscular disorders, traumatic brain and spinal cord injuries, strokes, non-healing wounds, cardiac disorders, renal disorders, and cancer.

The stock decreased 0.27% or $0.05 during the last trading session, reaching $18.65. About 543,140 shares traded or 7.46% up from the average. Select Medical Holdings Corporation (NYSE:SEM) has risen 31.29% since June 13, 2017 and is uptrending. It has outperformed by 18.72% the S&P500. Some Historical SEM News: ; 02/04/2018 – Fidelity Select Medical Equipment Adds Edwards Life; 23/04/2018 – DJ Select Medical Holdings Corporation, Inst Holders, 1Q 2018 (SEM); 03/05/2018 – Select Medical Sees 2018 EPS 93c-EPS $1.08; 03/05/2018 – SELECT MEDICAL 1Q OPER REV. $1.25B, EST. $1.23B; 03/05/2018 – SELECT MEDICAL HOLDINGS CORP SEM.N SEES FY 2018 ADJUSTED SHR $0.97 TO $1.12; 03/05/2018 – Select Medical Sees FY Rev $5B-$5.2B; 03/05/2018 – Baylor Scott & White Health and Select Medical Expand Joint Venture into the Austin Area; 16/05/2018 – Call for Papers Now Open For 6th Annual National Post-Acute Care Safety and Quality Summit; 03/05/2018 – SELECT MEDICAL HOLDINGS REAFFIRMS 2018 OUTLOOK; 29/03/2018 Select Medical Closes Below 200-Day Moving Average: Technicals

The Exec. Chairman and Co-Founder of Select Medical Holdings Corp, Robert Ortenzio is in the stock market news today. It was stated in a legal document filled by Robert Ortenzio and submitted to the U.S. Security and Exchange Commission on 12-06-2018, he sold 192,853 shares from the Pinksheet-listed Select Medical Holdings Corp valued at near $3,595,035 USD. The shares average price was $18.6. In the last month, he also unloaded 286,095 shares with a total value of about $5,304,270 USD. The chance of this trade staying unnoticed is very low because it’s huge one, with the Exec. Chairman and Co-Founder now having 8.09 million shares – that is 6.04% of the company’s market cap.

Analysts await Select Medical Holdings Corporation (NYSE:SEM) to report earnings on August, 2. They expect $0.36 EPS, up 12.50% or $0.04 from last year’s $0.32 per share. SEM’s profit will be $48.26 million for 12.95 P/E if the $0.36 EPS becomes a reality. After $0.29 actual EPS reported by Select Medical Holdings Corporation for the previous quarter, Wall Street now forecasts 24.14% EPS growth.

Since February 26, 2018, it had 0 insider purchases, and 6 sales for $5.46 million activity. $59,015 worth of Select Medical Holdings Corporation (NYSE:SEM) shares were sold by ORTENZIO ROBERT A. On Monday, February 26 the insider ROMBERGER SCOTT A sold $92,302. $61,807 worth of Select Medical Holdings Corporation (NYSE:SEM) was sold by Breighner Robert G. JR on Tuesday, May 8.

Investors sentiment increased to 1.45 in Q1 2018. Its up 0.35, from 1.1 in 2017Q4. It improved, as 14 investors sold Select Medical Holdings Corporation shares while 50 reduced holdings. 37 funds opened positions while 56 raised stakes. 100.83 million shares or 0.14% more from 100.69 million shares in 2017Q4 were reported. Great West Life Assurance Communications Can has invested 0.01% of its portfolio in Select Medical Holdings Corporation (NYSE:SEM). Legal General Grp Inc Plc has 261,226 shares for 0% of their portfolio. Bridgeway Cap Mngmt owns 385,000 shares. Illinois-based Nuveen Asset Management Ltd Liability Corporation has invested 0.01% in Select Medical Holdings Corporation (NYSE:SEM). Moreover, Gam Holdings Ag has 0.03% invested in Select Medical Holdings Corporation (NYSE:SEM) for 46,517 shares. Loomis Sayles And Limited Partnership accumulated 469 shares or 0% of the stock. Virtu Fincl Ltd Liability holds 0.01% or 12,743 shares. Cwm Lc reported 0% stake. Cordasco Ntwk holds 500 shares or 0.01% of its portfolio. Piedmont Investment Advsr Ltd Com accumulated 22,882 shares. Cornercap Inv Counsel accumulated 0.12% or 49,100 shares. Moreover, State Of Wisconsin Board has 0.01% invested in Select Medical Holdings Corporation (NYSE:SEM) for 130,400 shares. Teachers Retirement Sys Of The State Of Kentucky has invested 0.01% in Select Medical Holdings Corporation (NYSE:SEM). Cornerstone Advsr reported 0% stake. Parkside National Bank And Tru invested in 710 shares or 0% of the stock.

Select Medical Holdings Corporation (NYSE:SEM) Institutional Positions Chart